Radoslav Chekerov

Stable expansion of high‐grade serous ovarian cancer organoids requires a low‐Wnt environment

Karen Hoffmann, Hilmar Berger, Hagen Kulbe et al. · The EMBO Journal · 2020 · 253 citations · Full text

Medicine, Gynecology, Oncology +16

The time interval from surgery to start of chemotherapy significantly impacts prognosis in patients with advanced serous ovarian carcinoma — Analysis of patient data in the prospective OVCAD study

Gerda Hofstetter, Nicole Concin, Radoslav Chekerov et al. · Gynecologic Oncology · 2013 · 135 citations

Medicine, Oncology, Surgery +11

Prognostic Value of Residual Tumor Size in Patients With Epithelial Ovarian Cancer FIGO Stages IIA-IV

Stephan Polterauer, Ignace Vergote, Nicole Concin et al. · International Journal of Gynecological Cancer · 2012 · 109 citations

Medicine, Oncology, Surgery +17

Sorafenib plus topotecan versus placebo plus topotecan for platinum-resistant ovarian cancer (TRIAS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Radoslav Chekerov, Felix Hilpert, Sven� Mahner et al. · The Lancet Oncology · 2018 · 109 citations

Medicine, Oncology, Pharmacology +13

Prognostic significance of Dicer expression in ovarian cancer—link to global microRNA changes and oestrogen receptor expression

Areeg Faggad, Jan Budczies, Oleg Tchernitsa et al. · The Journal of Pathology · 2009 · 97 citations

Medicine, Molecular Biology, Oncology +17